Skip to main content

Why You Should Participate in the Voluntary FDA Oncology Center of Excellence Assessment Aid Program

In 2018, the FDA’s Oncology Center of Excellence developed an Assessment Aid document to help facilitate review of New Drug Applications (NDAs)/Biologics License Applications (BLAs) (including supplements) submitted to the Center for Drug Evaluation and Research’s (CDER’s) Office of Oncology Diseases (OOD). Providing the Assessment Aid with your NDA/BLA is voluntary. As noted by the … Continued

1 of 1
Powered by GlobalLink OneLink Software